glp-1 nmda receptor antagonist coupled to GLP1 analogue in highly effective experimental weight loss drug Neuroprotective effects of glucagon-like peptide-1

J Cutan Pathol 2006 Apr;33(4):261-79 Available from: Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R

Taking Caution Weight loss itself can come with negative mental health consequences, and many have certain expectations about how taking GLP-1 will affect their body

Ipamorelin is not a licensed medicine or drug and has not been approved by the MHRA, FDA, or any regulatory authority for human or veterinary use

No pharmacological evidence currently supports a direct anti-inflammatory or sebum-regulating effect of GLP-1 agonists on the pilosebaceous unitthe primary site of acne pathology

Janez A, Muzurovic E, Bogdanski P, et al

Related Reading Semaglutide For Weight Loss 2 Semaglutide Tablets For Weight Loss Semaglutide Pills For Weight Loss Oral Semaglutide Weight Loss Pricing and availability current as of June 2026